[First clinical observations on the effect of MABL preparation].
D000293:Adolescent; D000328:Adult; D001463:Barbiturates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*
D001463:Barbiturates; D007783:Lactones; D011725:Pyridines
Pierwsze spostrzezenie kliniczne nad działaniem przetworu MABL.